U.S. says use of Pfizer's COVID-19 antiviral up 315%
By Ahmed AbouleneinWASHINGTON, May 17 (Reuters) - Use of Pfizer Inc's COVID-19 oral antiviral treatment Paxlovid has jumped 315% over the past four weeks,...
By Ahmed AbouleneinWASHINGTON, May 17 (Reuters) - Use of Pfizer Inc's COVID-19 oral antiviral treatment Paxlovid has jumped 315% over the past four weeks,...